Health ❯Pharmaceuticals ❯Drug Development
SpringWorks Therapeutics BioNTech Antibody Therapies
The German pharmaceutical giant adjusts its guidance due to US tariffs and currency volatility but remains optimistic about growth, bolstered by a strategic acquisition of SpringWorks Therapeutics.